Kerry Fenwick

Kerry Fenwick

UNVERIFIED PROFILE

Are you Kerry Fenwick?   Register this Author

Register author
Kerry Fenwick

Kerry Fenwick

Publications by authors named "Kerry Fenwick"

Are you Kerry Fenwick?   Register this Author

54Publications

1785Reads

39Profile Views

An in vivo functional screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressor.

Cancer Discov 2014 Mar 11;4(3):304-17. Epub 2014 Feb 11.

1The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research; 2Cardiovascular Division, King's College London, British Heart Foundation Centre for Research Excellence, James Black Centre; and 3Division of Molecular Biosciences, Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0287DOI Listing
March 2014

Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity.

Cancer Res 2014 Jan 15;74(1):287-97. Epub 2013 Nov 15.

Authors' Affiliations: The CRUK Gene Function Laboratory, Functional Genomics Laboratory, Breakthrough Breast Cancer Research Centre, and Tumour Profiling Unit, The Institute of Cancer Research, London, United Kingdom.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-13-2541DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886090PMC
January 2014

Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study.

Clin Cancer Res 2013 Oct 6;19(19):5485-93. Epub 2013 Aug 6.

Authors' Affiliations: The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton; Edinburgh Cancer Research UK Center, Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh; The Cancer Research UK Gene Function Laboratory; Breakthrough Breast Cancer Research Center; Tumour Profiling Unit, The Institute of Cancer Research, London, United Kingdom; University of California San Francisco, San Francisco, California; Department of Medical Oncology, Prince of Wales Clinical School, Prince of Wales Hospital, Sydney, Australia; The Chaim Sheba Medical Center, Tel Hashomer, Israel; Princess Margaret Hospital, Toronto, Canada; Oncologisch Centrum Vrije Universiteit Brussel, Brussels, Belgium; and Dana Farber Cancer Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1262DOI Listing
October 2013

Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen.

Proc Natl Acad Sci U S A 2012 Feb 11;109(8):2730-5. Epub 2011 Apr 11.

Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, Institute of Cancer Research, London SW3 6JB, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1018872108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286962PMC
February 2012

Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor.

Genes Chromosomes Cancer 2011 Dec 31;50(12):982-95. Epub 2011 Aug 31.

Molecular Haematology and Cancer Biology Unit, University College London, Institute of Child Health, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20907DOI Listing
December 2011

Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas.

Clin Cancer Res 2011 Mar;17(6):1521-34

Department of Gynaecologic Oncology, Royal Marsden Hospital NHS Foundation Trust, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-1688DOI Listing
March 2011

A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines.

Breast Cancer Res Treat 2009 Dec 24;118(3):481-98. Epub 2009 Jan 24.

The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, Fulham Road, London, SW3 6JB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-008-0296-7DOI Listing
December 2009

Molecular response to aromatase inhibitor treatment in primary breast cancer.

Breast Cancer Res 2007 ;9(3):R37

The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, Fulham Road, London, SW3 6JB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr1732DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929101PMC
September 2007

Delineation of a 1Mb breakpoint region at 1p13 in Wilms tumors by fine-tiling oligonucleotide array CGH.

Genes Chromosomes Cancer 2007 Jun;46(6):607-15

Paediatric Oncology, Institute of Cancer Research/Royal Marsden NHS Trust, Sutton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20446DOI Listing
June 2007

Array CGH of fusion gene-positive leukemia-derived cell lines reveals cryptic regions of genomic gain and loss.

Genes Chromosomes Cancer 2006 Jun;45(6):554-64

Section of Haemato-Oncology, Institute of Cancer Research, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20317DOI Listing
June 2006

Array CGH using whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNA.

Genomics 2006 Feb 2;87(2):298-306. Epub 2005 Nov 2.

Paediatric Oncology, Institute of Cancer Research/Royal Marsden NHS Trust, Sutton, Surrey SM2 5NG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygeno.2005.09.019DOI Listing
February 2006